Drugs / GR270773
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT00158769 | Mar → Oct 2005 | infectious disease with sepsis | GlaxoSmithKline | Completed | No outcome recorded |
| Phase 21 trial · 1 missed | ||||||
| Phase 2 | NCT00089986 | Sep 2004 → Apr 2007 | bacterial infectious disease with sepsis | GlaxoSmithKline | Completed | Missed primary |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | GR270773 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00089986 ↗ |
| Route | Intravenous | “Intravenous GR270773- Phospholipid Emulsion” NCT00089986 ↗ |